Industry Partners & Collaborators

A global biopharmaceutical leader headquartered in Bengaluru, India, Biocon is one of the world's largest manufacturers of insulin analogs and biosimilars including insulin glargine, trastuzumab, and bevacizumab. Biocon's biosimilar portfolio serves patients across more than 120 countries.

Gan & Lee is China's leading insulin manufacturer and one of the world's top producers of recombinant insulin and GLP-1 analogs. The company holds approvals in over 70 countries and is a key global supplier of insulin glargine, insulin aspart, and liraglutide biosimilars.

Tonghua Dongbao is one of China's largest insulin manufacturers, producing recombinant human insulin and insulin analogs at scale. With decades of GMP-certified production experience and a robust biosimilar pipeline, Dongbao is a key strategic partner for insulin supply chain redundancy in the US market.

Sinoway Industrial is a leading Chinese supplier of pharmaceutical-grade peptide APIs and GLP-1 intermediates, with GMP-certified manufacturing facilities and a broad catalog of custom synthesis capabilities. Sinoway supports MayMag's peptide manufacturing pipeline with high-purity active pharmaceutical ingredients.

Yifan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer specializing in peptide APIs, small molecule synthesis, and injectable drug products. The company operates GMP-certified facilities and supplies active pharmaceutical ingredients to global CDMO and formulation partners.

Apino Pharma is a Turkish pharmaceutical company focused on the development and manufacture of biosimilar peptides and injectable biologics. With EU-GMP certified production facilities, Apino supplies biosimilar APIs and finished drug products to regulated markets across Europe and the Middle East.